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Abstract
Background: Acid phosphatase locus 1 and adenosine deaminase locus 1 polymorphisms show cooperative effects on glucose
metabolism and immunological functions. The recent observation of cooperation between the two systems on susceptibility to
repeated spontaneous miscarriage prompted us to search for possible interactional effects between these genes and the
correlation between birth weight and placental weight. Deviation from a balanced development of the feto-placental unit has
been found to be associated with perinatal morbidity and mortality and with cardiovascular diseases in adulthood.
Methods: We examined 400 consecutive newborns from the Caucasian population of Rome. Birth weight, placental weight,
and gestational length were registered. Acid phosphatase locus 1 and adenosine deaminase locus 1 phenotypes were determined
by starch gel electrophoresis and correlation analysis was performed by SPSS programs. Informed verbal consent to participate
in the study was obtained from the mothers.
Results: Highly significant differences in birth weight-placental weight correlations were observed among acid phosphatase
locus 1 phenotypes (p = 0.005). The correlation between birth weight and placental weight was markedly elevated in subjects
carrying acid phosphatase locus 1 phenotypes with medium-low F isoform concentration (A, CA and CB phenotypes) compared
to those carrying acid phosphatase locus 1 phenotypes with medium-high F isoform concentration (BA and B phenotypes) (p =
0.002). Environmental and developmental variables were found to exert a significant effect on birth weight-placental weight
correlation in subjects with medium-high F isoform concentrations, but only a marginal effect was observed in those with
medium-low F isoform concentrations. The correlation between birth weight and placental weight is higher among carriers of
the adenosine deaminase locus 1 allele*2, which is associated with low activity, than in homozygous adenosine deaminase locus
1 phenotype 1 carriers (p = 0.04). The two systems show a cooperative effect on the correlation between birth weight and
placental weight: the highest value is observed in newborns carrying adenosine deaminase locus 1 allele*2 and acid phosphatase
locus 1 phenotypes with medium-low F isoform concentration (p = 0.005).
Conclusion: These data suggest that zygotes with low adenosine deaminase locus 1 activity and low F activity may experience
the most favourable intrauterine conditions for a balanced development of the feto-placental unit.
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Background
We have recently described a cooperative interaction
between ACP1 (acid phosphatase locus 1) and ADA1 (ade-
nosine deaminase locus 1) genetic polymorphisms con-
cerning their effects on the susceptibility to spontaneous
primary repeated miscarriages: women carrying the
ADA1*2 and ACP1*C alleles show the lowest susceptibil-
ity to repeated miscarriages [1]. Both systems share impor-
tant effects on glucose metabolism and immunological
function. These observations prompted us to search for a
possible cooperative interaction between the two systems
regarding their effects on developmental parameters dur-
ing intrauterine life.
It is likely that a balanced growth of the two portions of
the feto-placental unit (i.e. without the prevalence of pla-
cental on the fetal part or vice versa) represents an advan-
tage for fetal development. The birth weight/placental
weight ratio (BW/PW) has been found to be correlated
with perinatal morbidity and mortality and with cardio-
vascular disease in adulthood [2,3]. There is evidence that
in addition to maternal factors and socioeconomic status,
genetic factors also influence the ratio BW/PW [3-5]. In a
recent note we have proposed the correlation between BW
and PW as an index of balanced development of the feto-
placental unit and have shown that this correlation is
influenced by ACP1 phenotype [6].
The ACP1 genetic polymorphism
ACP1 also called low molecular weight phospho-protein
tyrosine phosphatase (LMPTP) is an enzyme controlled
by a locus on chromosome 2 showing three common alle-
les: ACP1*A, ACP1*B, ACP1*C. These three alleles are
associated with different enzymatic activities [7]. Activity
of ACP1 phenotypes are in te following order: A < BA < B
= CA < CB < C [8].
Each allele at the ACP1 locus encodes two isoforms, called
F (fast) and S (slow) [9,10]. ACP1 B and BA show a
medium-high F isoform activity while CB, A, CA and C
phenotypes show a medium-low F isoform activity. ACP1
C, CA and CB show a much higher activity of S isoform as
compared to other ACP1 phenotypes [7,10].
Two important functions have been suggested for ACP1:
flavin-mono-nucleotide phosphatase activity and tyrosine
phosphatase activity [11-13]. Catalysing the conversion of
flavin-mononucleotide (FMN) to riboflavin, ACP1 may
have a role in regulating the cellular concentration of fla-
vin-adenine-dinucleotide (FAD), flavo-enzyme activity
and energy metabolism. As a phosphotyrosine phos-
phatase, the enzyme may have an important role in cellu-
lar growth regulation and in modulation of glycolytic rate
through the control of receptor activities and of band 3
protein phosphorylation status [[12,14] and [15]].
Recently it has been shown that ACP1 specifically dephos-
phorylates the negative regulatory Tyr-292 of ZAP-70,
thereby counteracting inactivation of ZAP-70. The ZAP-70
protein-tyrosine kinase plays a central role in signalling
from the T cell receptor. Thus, these results indicate that
ACP1 strengthens T cell receptor signalling [16].
The ADA1 genetic polymorphism
ADA1 is a polymorphic enzyme present in all mammalian
tissues [17]. It is controlled by a locus with two codomi-
nant alleles ADA*1 and ADA*2 located on the long arm
of chromosome 20. The corresponding three common
ADA1 phenotypes have different enzymatic activities: the
ADA11 phenotype is 15% more active than the ADA12/1
phenotype and 30% more active than the ADA12 pheno-
type, which is very rare [18].
ADA1 catalyses the irreversible deamination of adenosine
to inosine. Red Blood Cells (RBC) are in equilibrium with
freely diffusing adenosine [19], pointing to an important
role for this enzyme in the regulation of adenosine con-
centration.
Current interest has been focused on a wide variety of
effects produced by adenosine via activation of cell surface
adenosine receptors [20,21]. Adenosine counteracts insu-
lin action in the liver by activating A2B receptors [22].
Adenosine seems to facilitate insulin action in adipocytes.
The adenosine deaminase complex protein [23] (ADPC)
is identical with CD26, a T cell activating antigen and with
a glycoprotein present in epithelial cells of various tissues.
Recent data suggest that ADA1 and CD26 are co-localized
on the T cell surface but not inside cells.
Cells expressing ADA1 and CD26 on the surface are much
more resistant to the inhibitory effects of adenosine.
These data suggest that ADA1  on the cell surface is
involved in an important immunoregulatory mechanism
by which released ADA1 binds to the cell surface of CD26,
and this complex is capable of reducing the local concen-
tration of adenosine [24].
In the present paper we have performed a more detailed
analysis of the effect of ACP1 polymorphism and have
extended this study to the ADA1 polymorphism. On the
basis of the observations on women with repeated spon-
taneous miscarriages we would expect an optimal devel-
opmental context in zygotes carrying the ADA1*2 and
ACP1*C alleles.
Methods
In the present study we examined 400 consecutive new-
born infants from healthy puerperae. All infants were
Caucasian from the population of Rome. Birth weight andReproductive Biology and Endocrinology 2008, 6:38 http://www.rbej.com/content/6/1/38
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placental weight (wet, untrimmed) were registered in the
delivery room. Gestational length was estimated from the
date of the last menstrual period and checked against
Dubowitz score as an additional index of neonatal matu-
rity. Multiples were excluded. Mode of delivery does not
alter the phenotype of enzyme considered.
The data presented in the paper were collected a few years
ago and at that time there was not an established Ethical
Committee. The project was discussed and approved in
the Department. Informed verbal consent to participate in
the study was obtained from the mothers. This has been
recently (April 28, 2008) approved by the Institutional
Ethical Committee.
Newborn blood samples were obtained from the placen-
tal side of the umbilical vein after umbilical cord section.
The ACP1 phenotype was determined in 361 newborns by
starch gel electrophoresis on red blood cell hemolysates
according to Harris and Hopkinson [25]. The acid phos-
phatase pattern is revealed by a solution of phenol-
phtalein diphosphate: the addition of ammonium
solution reveals the area where phenolphtalein has been
liberated in the areas of gel where ACP1 activity is present.
In European populations the presence of three common
alleles *A, *B and *C determines the occurrence of six
phenotypes: A, AB, B, AC, BC and C. Each of the
homozygous A, B and C phenotypes are composed of two
fractions, F and S, corresponding to fast and slow compo-
nents of the electrophoretic pattern. Heterozygous pheno-
types have a pattern corresponding to a mixture of
homozygous types.
The ADA1 phenotype was determined by starch gel elec-
trophoresis on red blood cell hemolysates according to
Spencer et al [26]. Inosine produced at the sites of ADA1
activity is converted in hypoxanthine in the presence of
nucleoside phosphorylase and phosphate. The hypoxan-
thine is then oxidized by the action of xanthine oxidase,
and during this reaction the tetrazolium salt MTT is
reduced in the presence of phenazine methosulphate to a
blue insoluble formazan. In the ADA11 type there are
three regularly spaced components which exhibit decreas-
ing staining intensity in order of their anodal electro-
phoretic mobilities. In the ADA12 type there are also three
isozymes and their relative intensities and relative electro-
phoretic mobilities are very similar to those of the ADA11
pattern. The difference between ADA11 and ADA12 is that
the ADA12 pattern is appreciably slower than the ADA11
pattern. The pattern exhibiting four isozymes, designated
ADA12/1, has the appearance of a mixture of ADA11 and
ADA12 patterns.
In the last few years, in our laboratory, determination of
ADA1 and ACP1 genotypes has been performed routinely
on DNA. In our laboratory the comparison of classical
with DNA methods has shown practically no differences
between phenotypic and genotypic classifications. On a
sample of 50 subjects in which ACP1 and ADA1 pheno-
types were determined by DNA and classical methods
only one difference was observed for ACP1 and no differ-
ence for ADA1.
Correlation analysis was performed by SPSS programs.
Differences between correlation coefficients were evalu-
ated according to Snedecor and Cochran [27]. The distri-
bution of ACP1 phenotypes among newborns does not
differ statistically from Hardy-Weinberg expectation.
Results
Table 1 shows demographic parameters of the sample
study. Table 2 shows the distribution of ACP1 phenotypes
and developmental parameters for each phenotype. No
statistical significant difference among ACP1 phenotypes
is observed for BW, PW and gestational duration. CA phe-
notype shows low values for all parameters, but these val-
ues are not statistically different from those of other ACP1
phenotypes. BW-PW correlation analysis shows highly
significant differences among ACP1 phenotypes. The high-
est correlation coefficient is observed for CA phenotype
and the lowest for B phenotype.
Figures 1, 2, 3, and 4 illustrate the relationship between
BW-PW correlation and relevant ACP1 parameters: F and S
activity, F/S activity ratio and total activity. The BW-PW
correlation is negatively associated with F concentration
(Fig 1) and F/S ratio (Fig 3). A, CA and CB phenotypes
that share a medium-low F activity and F/S ratio have a
high BW-PW correlation, while the B phenotype, which
has the highest F activity and F/S ratio, has a low BW-PW
correlation. No association is observed for S isoform con-
centration (Fig 2) and ACP1 total activity (Fig 4).
Table 3 shows the effect of smoking, maternal age, gesta-
tional age, parity and gender on the relationship between
ACP1 and BW-PW correlation. For this analysis two
classes of ACP1 phenotypes have been considered: A, CA,
CB phenotypes with medium-low F activity, and B and BA
phenotypes with medium-high F activity. In A, CA, CB
Table 1: Maternal and neonatal parameters in the sample study
Mean Proportion S.E.
Maternal Age (yrs) 28.5 0.3
Gestational Age (wks) 39.6 0.12
Birth Weight (gr) 3269 29
Placental Weight (gr) 578 8
Smokers 38%
Male Infant 54%Reproductive Biology and Endocrinology 2008, 6:38 http://www.rbej.com/content/6/1/38
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phenotypes only maternal age exhibits some effect on the
BW-PW correlation, while among B and BA phenotypes
most variables show highly significant effects on the BW-
PW correlation.
Table 4 shows the distribution of ADA1 phenotypes and
developmental parameters for the ADA11 phenotype and
for carriers of the ADA1*2 allele. The BW-PW correlation
coefficient is higher among carriers of the ADA1*2 allele
than among ADA11 phenotype carriers (p = 0.04). No sig-
nificant difference between ADA1 phenotypes has been
observed for BW, PW and gestational duration.
Table 5 shows the effect of smoking, maternal age, gesta-
tional age, parity and gender on the relationship between
ADA1 and BW-PW correlation. Significant effects of these
variables were observed in the correlations of BW-PW in
both ADA1 subjects and in carriers of the ADA1*2 allele.
The BW-PW correlation is influenced by environmental
and developmental variables, but as shown in tables 3
and 5 the differential effects of ACP1 and ADA1 pheno-
types on this correlation do not appear in general to be
significantly influenced by these variables.
Table 6 shows the correlation between BW and PW
according to the joint ACP1-ADA1 phenotype. Both ADA1
and ACP1 phenotypes were determined in 327 infants.
There is a highly significant difference among joint phe-
notypes (p = 0.000): the highest correlation is observed in
subjects who carry A or CA or CB phenotypes and the
ADA1*2 allele, while the lowest correlation is observed
when the ADA1 1 phenotype is associated with B or BA
phenotypes.
Discussion and conclusion
The present data suggest that foetuses with low ADA1
activity, associated with medium-low ACP1  F isoform
activity, have the best correlation between BW and PW,
suggesting a most favourable situation for the develop-
ment of the feto-placental unit. These observations agree
with those expected on the basis of previous data on
women with repeated spontaneous miscarriages that
demonstrated a cooperative protective effect of ADA1*2
and ACP1*C alleles against fetal loss. Thus, the two lines
of evidence support the hypothesis that foetuses with low
ADA1 activity and low ACP1 F isoform activity have a bal-
anced development of feto-placental unit and a higher
probability of survival compared to other foetuses.
Table 2: Distribution of neonatal parameters in relation to ACP1 phenotypes.
ACP1 phenotypes Significance of difference among phenotypes (p)
AB CB A C A C B
Absolute frequencies 34 163 2 123 9 30
Percent frequencies 9.4% 45.2% 0.6% 34.1% 2.5% 8.3%
Birth weight (gr)
Mean 3345 3250 3645 3338 2837 3244 0.141 (*)
S.E. 85 46 575 44 333 90
Placental weight(gr)
Mean 590 594 615 571 517 540 0.491(*)
S.E. 23 17 135 12 46 21
Gestational age(wks)
Mean 40.00 39.61 39.50 39.77 38.11 39.53 0.405(*)
S.E. 0.41 0.20 1.50 0.15 1.57 0.40
Median 40.00 40.00 39.50 40.00 40.00 40.00
Correlation between birth weight and placental 
weight (r)
0.69 0.18 - 0.31 0.77 0.68 0.005(**)
Significance of r (p) 0.001 0.029 - 0.001 0.025 0.001
Significance of differences among means (*) refers to Variance analysis. Significance of differences among correlation coefficients (**) has been 
calculated according to Snedecor and Cochran.Reproductive Biology and Endocrinology 2008, 6:38 http://www.rbej.com/content/6/1/38
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The relationship between F/S isoform concentration and  BW-PW correlation Figure 3
The relationship between F/S isoform concentration 
and BW-PW correlation. The term BW-PW correlation 
expresses the correlation between birth weight and placental 
weight. ACP1 is the acid phosphatase locus 1. A, B, C, BA, 
CA, CB are the ACP1 phenotypes. In abscissa F/S isoform 
concentrations of each ACP1 phenotype are also reported. 
The rank correlation coefficient according to Spearman (27) 
between BW-PW correlation and F/S isoform concentration 
is rs = -0.9, p < 0.05.
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The relationship between F isoform concentration and BW- PW correlation Figure 1
The relationship between F isoform concentration 
and BW-PW correlation. The term BW-PW correlation 
expresses the correlation between birth weight and placental 
weight. ACP1 is the acid phosphatase locus 1. A, B, C, BA, 
CA, CB are the ACP1 phenotypes. In abscissa F isoform con-
centrations of each ACP1 phenotype are also reported. The 
rank correlation coefficient according to Spearman (27) 
between BW-PW correlation and F isoform concentration is 
rs = -1, p < 0.01.
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The relationship between S isoform concentration and BW- PW correlation Figure 2
The relationship between S isoform concentration 
and BW-PW correlation. The term BW-PW correlation 
expresses the correlation between birth weight and placental 
weight. ACP1 is the acid phosphatase locus 1. A, B, C, BA, 
CA, CB are the ACP1 phenotypes. In abscissa S isoform con-
centrations of each ACP1 phenotype are also reported. The 
rank correlation coefficient according to Spearman (27) 
between BW-PW correlation and S isoform concentration is 
rs = 0.3, p not significant.
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The relationship between F+S isoform concentration and  BW-PW correlation Figure 4
The relationship between F+S isoform concentration 
and BW-PW correlation. The term BW-PW correlation 
expresses the correlation between birth weight and placental 
weight. ACP1 is the acid phosphatase locus 1. A, B, C, BA, 
CA, CB are the ACP1 phenotypes. In abscissa F+S isoform 
concentrations of each ACP1 phenotype are also reported. 
The rank correlation coefficient according to Spearman (27) 
between BW-PW correlation and F+S isoform concentration 
is rs = 0.3, p not significant.
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The exact mechanism underlying the statistical associa-
tion of ADA1 and ACP1 with the BW-PW correlation is not
known at present. An immunological mechanism is sup-
ported by the well known relationship between ADA1 and
immune diseases and between ACP1 and T cell activation.
A relative depression of T cell activation due to low level
of F ACP1 isoform and to higher concentration of adenos-
ine (due to the low activity of ADA1*2 carriers) could
modulate the feto-maternal immunological relationship
resulting in a balanced development of the two portions
of feto-placental unit.
A metabolic mechanism may be operative in which ACP1,
acting as phosphotyrosine phosphatase, could have an
important role in the modulation of glycolytic rate
through the control of insulin receptor activity and of
band 3 protein phosphorylation status. Additionally, cat-
alysing the conversion of flavin-mononucleotide (FMN)
in riboflavin, the enzyme may influence flavo-enzyme
activity and energy metabolism [7]. In turn, with respect
to ADA1 activity, recent studies have shown that adenos-
ine counteracts insulin action in the liver by activating
A2B receptors [20-22]. On the basis of these actions on
glucose metabolism, ACP1 F isoform activity coupled with
low ADA1 activity could have favourable effects on the
development of the feto-placental unit.
Table 3: Correlation between birth weight and placental weight in relation to ACP1 F isoform activity.
ACP1 F isoform activity
Sample Medium-high (B+BA) Medium-low (A+CA+CB)
rp * r p *
All subjects 0.209 0.001 0.687 0.000
Smoking
Yes 0.122 0.243 0.696 0.000
no 0.241 0.002 0.710 0.000
Significance of difference p** 0.000 0.750
Maternal age (yrs)
≤28 0.027 0.745 0.723 0.000
>28 0.478 0.000 0.640 0.000
Significance of difference p** 0.000 0.025
Gestational age (wks)
≤37 0.183 0.440 0.731 0.160
>37 0.228 0.000 0.655 0.000
Significance of difference p** 0.450 0.950
Birth order
1 0.305 0.001 0.672 0.000
≥ 2 0.158 0.060 0.703 0.000
Significance of difference p** 0.000 0.350
Sex
male 0.171 0.044 0.712 0.000
female 0.301 0.001 0.655 0.000
Significance of difference p** 0.000 0.170
Significance of difference between correlation coefficients has been calculated according to Snedecor and Cochran. p* refers to significance of 
correlation coefficient. p** refers to significance of difference between the two classes. For "All subjects" the difference of correlation coefficients 
between (B+BA) vs (A+CA+CB) i.e. 0.209 vs 0.687 is highly significant: p = 0.002.Reproductive Biology and Endocrinology 2008, 6:38 http://www.rbej.com/content/6/1/38
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Regarding the effect of genetic variability of ACP1 on the
correlation of BW with PW, it is interesting to speculate on
the possible selective advantage of the *A and *C alleles
over the *B allele. The *B allele is the most frequent in all
human populations, and the *A allele is present with var-
iable frequencies in all major ethnic groups, while *C
allele is present with appreciable frequencies only in Cau-
casians.
Our data suggest that the optimal BW-PW correlation is
seen in carriers of the ACP1*C allele and in the
homozygous A phenotype (table 4 and Fig 1), while the
heterozygous BA phenotype shows an intermediate value
between B and A (Fig 1). Interestingly, in A, CA and CB
phenotypes the BW-PW correlation is hardly influenced
by environmental circumstances, while in B and BA phe-
notypes the environmental variables exert considerable
effects on this correlation. Thus, ACP1*A and *C variants
could have a selective advantage during intrauterine life
on the fundamental ACP1*B allele. This might have con-
tributed to an increase in frequencies of the ACP1*A and
*C alleles to polymorphic values and could presently con-
tribute to maintenance of the ACP1 polymorphism in
human populations.
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Table 4: Parameters distribution of newborns in relation to ADA1 phenotypes.
ADA1 phenotypes Significance of difference between 
phenotypes (p)
ADA11( A D A 12/1+ADA12)
Absolute frequencies 317 58
Percent frequencies 84.5% 15.5%
Birth weight (gr)
Mean 3279 3311 0.612*
S.E. 32 54
Placental weight (gr)
Mean 584 545 0.103*
S.E. 10 13
Gestational age (wks)
Mean 39.63 39.84 0.505*
S.E. 0.13 0.24
Median 40.00 40.00
Correlation between birth weight and placental weight (r) 0.289 0.552 0.040**
Significance of r (p) 0.000 0.000
Significance of difference between means (*) refers to Variance analysis. Significance of difference between correlation coefficients (**) has been 
calculated according to Snedecor and CochranReproductive Biology and Endocrinology 2008, 6:38 http://www.rbej.com/content/6/1/38
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Table 5: Correlation between birth weight and placental weight in relation to ADA1 phenotypes.
ADA1 phenotypes
Sample ADA11( A D A 12/1+ADA12)
rp * r p *
All subjects 0.289 0.000 0.552 0.000
Smoking
Yes 0.275 0.003 0.484 0.036
no 0.288 0.000 0.589 0.000
Significance of difference p** 0.300 0.150
Maternal age (yrs)
≤28 0.104 0.181 0.679 0.000
>28 0.559 0.000 0.341 0.120
Significance of difference p** 0.000 0.000
Gestational age (wks)
≤37 0.292 0.187 0.922 0.078
>37 0.286 0.000 0.560 0.000
Significance of difference p** 0.900 0.350
Birth order
1 0.449 0.000 0.572 0.001
≥ 2 0.212 0.009 0.543 0.003
Significance of difference p** 0.000 0.700
Sex
male 0.268 0.000 0.359 0.078
females 0.344 0.000 0.692 0.000
Significance of difference p** 0.000 0.000
Significance of difference between correlation coefficients has been calculated according to Snedecor and Cochran. p* refers to significance of 
correlation coefficient. p** refers to significance of difference between the two classes. For "All subjects" the difference of correlation coefficients 
between ADA11 and (ADA12/1+ADA12) i.e. 0.289 vs 0.552 is statistically significant: p = 0.04.
Table 6: Correlation between birth weight (BW) and placental 
weight (PW) according to the joint ACP1-ADA1 phenotype.
Joint ACP1-ADA1 phenotype
Presence of ADA*2 allele - - + +
Presence of A or CA or CB types - + - +
BW-PW correlation coefficients (r) 0.193 0.613 0.648
Significance of r (p) 0.004 0.000 0.059
Total n° 217 101 9
Significance of difference among correlation coefficients p = 0.000. 
Significance of difference among correlation coefficients has been 
calculated according to Snedecor and CochranPublish with BioMed Central    and   every 
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